Introduction:
Pharma stock climbed 5.73% to ₹927.20 after reversing a loss with a ₹30.49 crore net profit in Q2FY25. EBITDA increased 566%, boosting the margin to 12.55%. Despite a revenue dip, cost reductions enhanced profitability, reflecting strong management and strategic operations. The firm’s extensive Indian manufacturing underpins its market stance.
Share Price movement of Unichem Laboratories:
On November 13, 2024, Unichem Laboratories experienced significant volatility in its stock price. The stock opened at ₹915.00, reached an intraday high of ₹927.20, but also dipped to a low of ₹826.00 before closing at ₹876.55. This movement reflects dynamic trading activity and a notable intraday price range.
Unichem Laboratories shares in focus:
Unichem Laboratories saw its shares climb by 5.73% to ₹927.20 following a notable turnaround in Q2FY25 with net profits of ₹30.49 crore, a significant recovery from a net loss last year. The company’s EBITDA soared 566%, improving the margin to 12.55%.
Despite an 11.32% decrease in quarterly revenue, the firm’s financial discipline led to a reduction in total expenses, contributing to the profitability. This performance demonstrates Unichem’s effective cost management and operational efficiency during the quarter.
Located in Mumbai, Unichem specialises in pharmaceuticals, operating multiple manufacturing facilities across India. The company’s strategic focus and expansive infrastructure support its sustained market presence and recent stock performance.
Also Read: Best Stocks for Kids to Invest In This Children’s Day 2024
Recent news About Unichem Laboratories:
As of November 11, 2024, Unichem Laboratories announced plans to enhance its international market presence. The expansion focuses on increasing production capacities and utilising its broad product range to meet escalating global demand, strategically aiming to elevate its footprint in essential overseas markets.
Stock performance of Unichem Laboratories for Period of 1 week, 6 months and 1 year:
Unichem Laboratories stock performance saw a modest rise of 0.38%. Over the last six months, the stock demonstrated a strong increase of 58.0%. Remarkably, over the past year, Unichem’s stock has surged, showing a significant return of 114%. This upward trend highlights the company’s robust market performance across various timeframes.
Also Read: Tara Chand Infralogistic stock in focus after it sets record date for 1:5 stock split
Shareholding pattern of Unichem Laboratories:
| All values in % | Sep-24 | Jun-24 | Mar-24 |
| Promoters | 70.22 | 70.22 | 70.22 |
| FII | 0.94 | 0.89 | 0.9 |
| DII | 11.65 | 11.57 | 11.26 |
| Retail & others | 17.17 | 17.32 | 17.63 |
About Unichem Laboratories:
Unichem Laboratories, established in Mumbai, is a renowned pharmaceutical company in India. It specialises in manufacturing active pharmaceutical ingredients (APIs) and a variety of pharmaceutical products. The company operates across four divisions and maintains five manufacturing facilities in different Indian states, serving both domestic and international markets.
